Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension

Southern Medical Journal

Volumn 94, Issue 11, 2001, Pages 1112-1117

  Burke, B E ^a   Neuenschwander, R ^a   Olson, R D ^a  

^a Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; HYDROSOLUBLE Q GEL; PLACEBO; UBIDECARENONE;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME;

EID: 0035652234     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200111000-00015     Document Type: Article

References (42)

1. Arterial hypertension
2. Isolated systolic hypertension in the elderly: Lessons from clinical trials and future directions
3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension, final results of the Systolic Hypertension in the Elderly Program (SHEP)
4. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
5. Postural hypotension and postural dizziness in elderly women, the study of osteoporotic fractures, the Study of Osteoporotic Fractures Research Group
6. Biochemical, physiological, and medical aspects of ubiquinone function
7. Overview of the use of CoQ10 in cardiovascular disease
8. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10
9. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting
10. Mechanism of action of coenzyme Q10 in essential hypertension
11. Treatment of essential hypertension with coenzyme Q10
12. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease
13. Effect of coenzyme Q10 on esential arterial hypertension
14. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10
15. Relative bioavailability of coenzyme Q10 formulations in human subjects
16. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP) Hypertension study
17. HPLC of coenzyme Q-related compounds and its application to biological materials
18. Clinical use of coenzyme Q for treatment of cardiovascular disease
19. Effect of coenzyme Q10 on experimental hypertension in the desoxycorticosterone acetate-saline loaded rats
20. Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10
21. Deficiency of activity, of succinate dehydrogenase-coenzyme Q10 reductase in leukocytes from patients with essential hypertension
22. Bioenergetics in clinical medicine, studies on coenzyme Q10 and essential hypertension
23. Bioenergetics in clinical medicine. VIII. Administration of coenzyme Q10 to patients with essential hypertension
24. Effect of coenzyme Q10 on essential hypertension: A double-blind controlled study
25. Bioavailabiltiy of four oral coenzyme Q10 formulations in healthy volunteers
26. Ubiquinone supplementation and exercise capacity in trained young and older men
27. The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men
28. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitiors: A double-blind, placebo-controlled study
29. Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
30. Age-related changes in vascular responses: A review
31. Physiology of cardiovascular aging
32. Aging and endothelial function in normotensive subjects and patients with essential hypertension
33. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans
34. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats
35. Insulin resistance in essential hypertension
36. Insulin resistance in essential hypertension: A psychophysiological approach to the "chicken and egg" question
37. Autonomic imbalance, hypertension, and cardiovascular risk
38. The sympathetic system and hypertension
39. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine
40. Italian multicenter study on safety and efficacy of coenzyme Q10 adjunctive therapy in heart failure
41. Biopharmaceutical aspects of intravenous and oral administration of coenzyme Q10
42. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey